Signature Series Sessions
The ‘Signature Series’ sessions at ACRP 2026 will inspire, motivate, and prepare you for what’s next. This year’s lineup includes thought leaders, industry experts, and regulatory officials driving innovation and change.
Embrace the Now, Ignite What’s Next
For years, the clinical research industry has pursued transformative changes—seeking smarter trials, more efficient processes, and improved patient outcomes. Today, those long-awaited advancements are no longer aspirational—they're happening. From decentralized trials and AI-driven insights to streamlined protocols and enhanced patient engagement, the future of clinical research is unfolding in real time.
Saturday, April 25, 9:00 — 10:15 AM
Barbara Bierer, Faculty Director, Harvard Medical School
Kevin Bugin, Associate Vice President of Global Regulatory Policy and Intelligence, Amgen
Morgan Hanger, Executive Director, Clinical Trials Transformation Initiative
Jennifer Byrne, Chief Executive Officer and Board Director, Javara (Moderator)
Next is You: Leadership as a Clinical Trial Competency
Clinical research is a dynamic field shaped by the people who plan, conduct, and oversee it at every career stage. This engaging panel brings together diverse voices to share their career journeys, the leadership skills that fueled their growth, and the pivotal moments that defined their paths.
Sunday, April 26, 9:00 — 10:15 AM
Michelle Rowe, RN, VP, Research, HCA Healthcare
Jennifer Sheller, ACRP-CP, Senior Vice President and Head, Global Clinical Trial Operations (GCTO), Merck
Muriel Maignan Wilkins, CEO & Founder, Paravis Partners
Susan P. Landis, Chief Executive Officer, Association of Clinical Research Professionals (Moderator)
What’s Next: Clinical Research Innovation
Clinical research is undergoing a dynamic transformation—propelled by breakthrough developments, evolving regulations, and fresh approaches to collaboration. David Burrow will offer strategic insights on elevating trial quality and minimizing regulatory uncertainty—sharing forward-thinking approaches and practical tools designed to help research professionals thrive in today’s complex and rapidly shifting environment.
Monday, April 27, 2:00 — 3:00 PM
David Burrow, PharmD, JD, Director, Office of Scientific Investigations, U.S. Food and Drug Administration